Hydrochloric Acid

Hydrochloric Acid

SCHEMBL108301

Cl.N[Zn]

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29078932 1.00
SCHEMBL530558 0.87
Ammonia Solution, Strong SCHEMBL8576297 0.75
SCHEMBL16782689 0.75
Fluoride SCHEMBL30914356 0.75
Hydrochloric Acid SCHEMBL1144150 0.75
Hydrochloric Acid SCHEMBL28858317 0.75
SCHEMBL28711336 0.75
Hydrazine SCHEMBL10894352 0.58
Hydrazine SCHEMBL64482 0.58

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 230 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023238000-A1 PROCESS FOR PREPARATION OF SELUMETINIB AND SALTS THEREOF GLENMARK LIFE SCIENCES LIMITED (IN) 2023-12-14 WO claimed
CN-115433119-A C5 branched 1-deoxynojirimycin derivative and preparation method and application thereof 中国科学院化学研究所 2022-12-06 CN claimed
WO-2019043635-A1 D-AMINO ACID OXIDASE ACTIVITY INHIBITING COMPOUNDS RICHTER GEDEON NYRT. (HU) 2019-03-07 WO claimed
US-8993789-B2 Process for preparing zanamivir and intermediates for use in the process CIPLA LIMITED (IN) 2015-03-31 US claimed
CN-101693708-B Azasugar compound containing aryl and preparation process and application thereof CHINESE ACAD INST CHEMISTRY 2014-09-24 CN claimed
EP-2358695-B1 PROCESS FOR PREPARING ZANAMIVIR AND INTERMEDIATES FOR USE IN THE PROCESS CIPLA LTD (IN) 2014-07-02 EP claimed
WO-2012146535-A1 PROCESS FOR THE PREPARATION OF 2-SUBSTITUTED 2,4-DIHYDRO-[1,2,4]TRIAZOLE-3-THIONES BASF SE (DE) 2012-11-01 WO claimed
EP-2476675-A1 Process for preparing zanamivir and intermediates for use in the process Cipla Limited (IN) 2012-07-18 EP claimed
US-20110257418-A1 Process for Preparing Zanamivir and Intermediates for Use in the Process CIPLA LIMITED (IN) 2011-10-20 US claimed
EP-2358695-A2 Process for preparing zanamivir and intermediates for use in the process CIPLA LIMITED (IN) 2011-08-24 EP claimed
CN-101200470-B Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof CHINESE ACAD INST CHEMISTRY 2010-10-13 CN claimed
WO-2010061182-A2 PROCESS FOR PREPARING ZANAMIVIR AND INTERMEDIATES FOR USE IN THE PROCESS CIPLA LIMITED (IN) 2010-06-03 WO claimed
CN-101693708-A Azasugar compound containing aryl and preparation process and application thereof CHINESE ACAD INST CHEMISTRY 2010-04-14 CN claimed
CN-101200470-A Cyclo c-glycosides compounds, c-glycosides intermediates as well as preparation method and uses thereof CHINESE ACAD INST CHEMISTRY (CN) 2008-06-18 CN claimed
WO-1997015696-A1 GALVANIZING ALLOY AND PROCESS FOR REACTIVE STEELS COMINCO LTD. (CA) 1997-05-01 WO claimed
US-12043620-B2 Benzazole compounds and methods for making and using the compounds RIGEL PHARMACEUTICALS, INC. (US) 2024-07-23 US disclosed
US-20240116866-A1 AMINATED PSILOCYBIN DERIVATIVES AND METHODS OF USING Enveric Biosciences Canada Inc. (CA) 2024-04-11 US disclosed
US-4352760-A Organic compounds substituted heptadeca-5,9- and 5,10-dienoic acid THE UPJOHN COMPANY (US) 1982-10-05 US disclosed
US-4125679-A IRON-ZINC INTERMETALLIC BETHLEHEM STEEL CORPORATION (US) 1978-11-14 US disclosed
US-4059711-A Partially alloyed galvanize product and method BETHLEHEM STEEL CORPORATION (US) 1977-11-22 US disclosed